Journal list menu
IssueMovement Disorders: Volume 20, Issue 3
271-388March 2005
Export Citations
Viewpoints
no
Challenging conventional wisdom: The etiologic role of dopamine oxidative stress in Parkinson's disease
- Pages: 271-282
- First Published: 09 March 2005
Research Reviews
no
Rodent models for dystonia research: Characteristics, evaluation, and utility
- Pages: 283-292
- First Published: 09 March 2005
Research Articles
no
Interrater agreement in the assessment of motor manifestations of Huntington's disease
- Pages: 293-297
- First Published: 09 March 2005
no
Harmaline-induced tremor as a potential preclinical screening method for essential tremor medications
- Pages: 298-305
- First Published: 09 March 2005
no
Multiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP-treated drug-naïve primates
- Pages: 306-314
- First Published: 09 March 2005
no
Disparities in the recording of Parkinson's disease on death certificates
- Pages: 315-321
- First Published: 09 March 2005
Brief Reports
no
Motor training as treatment in focal hand dystonia†
- Pages: 335-341
- First Published: 09 March 2005
no
Levodopa-dyskinesia incidence by age of Parkinson's disease onset
- Pages: 342-344
- First Published: 09 March 2005
no
Analysis of the course of Parkinson's disease under dopaminergic therapy: Performance of “fast tapping” is not a suitable parameter
- Pages: 348-354
- First Published: 09 March 2005
no
Abnormalities of sensory processing and sensorimotor interactions in secondary dystonia: A neurophysiological study in two patients
- Pages: 354-360
- First Published: 09 March 2005
no
Trial of subtherapeutic pergolide in de novo Parkinson's disease
- Pages: 363-366
- First Published: 09 March 2005
Genetic Briefs
no
Analysis of the glucocerebrosidase gene in Parkinson's disease
- Pages: 367-370
- First Published: 09 March 2005
Clinical/Scientific Notes
no
Pallidal deep brain stimulation influences both reflexive and voluntary saccades in Huntington's disease
- Pages: 371-377
- First Published: 09 March 2005
no
Bilateral subthalamic nucleus deep brain stimulation in a patient with cervical dystonia and essential tremor
- Pages: 377-380
- First Published: 09 March 2005
no
Sacsin-related autosomal recessive ataxia without prominent retinal myelinated fibers in Japan
- Pages: 380-382
- First Published: 09 March 2005
no
Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease
- Pages: 383-385
- First Published: 09 March 2005
Letters to the Editor
no
Valproate-induced parkinsonism: Use of a newer pharmacovigilance tool to investigate the reporting of an unanticipated adverse event with an “old” drug
- Pages: 387
- First Published: 09 March 2005
Letters to the Editors
no
Sensory tricks and treatment in primary lingual dystonia
- Pages: 388
- First Published: 09 March 2005
Errata
Free Access
free
Multiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP-treated drug-naïve primates
- Pages: 388
- First Published: 10 March 2005
Sign up for email alerts
Related Titles
Browse by Topics
Diagnostic techniques
- Autonomic function tests
- Diagnostic imaging
- Exercise stress test
- Finger dexterity test
- Functional balance assessment
- Gait analysis
- Genetic analysis
- Motor examination
- Neurophysiologic test
- Neuropsychological tests
- Olfactory test
- Postural assessment
- Suggested immobilization test
- Tremor evaluation
- Visual test
Disease rating scales
- Anxiety rating scale
- Apathy Evaluation Scale
- Ataxia rating scales
- Dementia rating scale
- Depression rating scale
- Dyskinesia rating scale
- Dystonia rating scale
- Huntington's disease rating scale
- Multiple system atrophy rating scale
- Myoclonus rating scale
- Other rating scales
- Parkinson disease rating scale
- Psychosis rating scale
- Sleep rating scale
- Spasticity rating scale
- Tic rating scale
- Tremor rating scale
Drug-induced movement disorders
Genetics of movement disorders
Hyperkinetic movement disorders
Hypokinetic movement disorders
Molecular mechanisms of movement disorders
Motor symptoms
Movement disorder associated diseases
Movement disorder associated diseases
- Autoimmune disease
- Infectious diseases
- Metabolic diseases
- Neurological diseases
- Akinetic mutism
- Alexander disease
- Alzheimer’s disease
- Ataxia
- Cerebrovascular disorders
- Cockayne syndrome
- Dentatorubral-pallidoluysian atrophy
- Fragile X syndrome
- Gaucher disease
- Hallervorden-Spatz disease
- Hemifacial spasm
- Hepatocerebral degeneration
- Hereditary spastic paraplegia
- Hyperekplexia
- Meige syndrome
- Neurodegeneration with brain iron accumulation syndrome
- Normal pressure hydrocephalus
- Optic atrophy
- Periodic leg movements
- Pisa syndrome
- Prion disease
- Restless legs syndrome
- Rett syndrome
- Stiff-person syndrome
- Tourette syndrome
- Unverricht-Lundborg syndrome
- Wilson's disease
- Nutritional deficiencies
- Paraneoplastic syndrome
Movement disorder management
- Allied therapies
- Botulinum neurotoxin
- Continuous subcutaneous apomorphine infusion
- Electrical stimulation therapy
- Electroconvulsive therapy
- Gene therapy
- Pharmacologic treatment
- Stereotactic surgery
Neuroanatomy of movement disorders
Non-motor symptoms
Functional movement disorders
